Less Ads, More Data, More Tools Register for FREE

Pin to quick picksWilmington Regulatory News (WIL)

Share Price Information for Wilmington (WIL)

Share Price is delayed by 15 minutes
Get Live Data
290.00    0.00 (0.00%)
Bid:
0.00
Ask:
0.00
Spread: 6.00 (2.166%)
Market Cap: £259.71m
WIL Live PriceLast checked at - London Stock Exchange

Intraday Wilmington Share Chart

Year-End Trading Update

27 Jul 2022 07:00

RNS Number : 8162T
Wilmington PLC
27 July 2022
 

27 July 2022

Wilmington plc

 

Year-end trading update - profitability ahead of expectations

 

Wilmington plc, (LSE: WIL, 'Wilmington', 'the Group') the provider of data, information, education and training in the global Governance, Risk and Compliance ('GRC') markets, today provides a trading update for the year ended 30 June 2022.

 

Group revenue is expected to be in the order of £121.0m (2021: £113.0m) with organic revenue growth of 13%. Events revenues were particularly strong in the US in H2. Overall organic revenue growth excluding events was 5%.

 

Adjusted profit before tax (unaudited) was ahead of expectations at £20.7m* (2021: £15.0m). Both divisions recorded double-digit organic revenue growth and improved profitability. 

 

Cash conversion has been strong with Group net cash on 30 June 2022 at £20.5m (31 December 2021: £11.0m; 30 June 2021: net debt £17.7m).

 

Wilmington expects to publish its year end results on 22 September 2022.

 

Mark Milner, Chief Executive Officer, commented:

 

"We are executing our strategy by growing revenues and profits organically in the large, expanding and rapidly evolving GRC markets by investing in our business and actively managing our portfolio of businesses.

 

"A combination of good organic revenue growth, tight control of overheads and a targeted reduction in lower margin business has resulted in this strong performance.

 

"We have also continued to see solid growth in our underlying recurring revenues, reflecting the resilience of the business overall."

 

*Adjusted profit before tax (PBT) is calculated as PBT after adding back amortisation of intangible assets except computer software and profits/losses on disposals and business closures.

 

For further information, please contact:

 

Wilmington plc

Mark Milner, Chief Executive Officer

Guy Millward, Chief Financial Officer

 

Meare Consulting

Adrian Duffield

 

 

020 7490 0049

 

 

 

07990 858548

 

The information contained within this announcement is deemed to constitute inside information as stipulated under the Market Abuse Regulations (EU) No. 596/2014. Upon the publication of this announcement this inside information is now considered to be in the public domain.

 

Notes to Editors

Wilmington plc is the recognised knowledge leader and partner of choice for data, information, education and training in the global Governance, Risk and Compliance (GRC) markets. Wilmington employs close to 1,000 people and sells to around 120 countries. Wilmington is listed on the main market of the London Stock Exchange.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
TSTZZGZNKVZGZZM
Date   Source Headline
10th Dec 20147:00 amRNSInterim Update on Business Review
1st Dec 20149:07 amRNSVoting Rights Announcement
20th Nov 20143:47 pmRNSShareholding Announcement
13th Nov 20143:40 pmRNSHolding(s) in Company
6th Nov 20145:11 pmRNSAGM Results 2014
6th Nov 20147:00 amRNSInterim Management Statement
3rd Nov 20141:39 pmRNSVoting Rights
27th Oct 201411:33 amRNSCorrection: Share Awards
20th Oct 20146:17 pmRNSCorrection: Share Awards
20th Oct 20145:10 pmRNSDirector/PDMR Shareholding
20th Oct 20145:09 pmRNSShare Awards
17th Oct 20143:54 pmRNSHolding(s) in Company
10th Oct 20144:16 pmRNSHolding(s) in Company
1st Oct 20141:46 pmRNSTotal Voting Rights
23rd Sep 201412:15 pmRNSShare Awards
18th Sep 20147:00 amRNSFinal Results
1st Sep 20145:16 pmRNSVoting Rights Announcement
1st Aug 20147:00 amRNSVoting Rights and Capital
14th Jul 20142:58 pmRNSHolding(s) in Company
14th Jul 20142:55 pmRNSHolding(s) in Company
1st Jul 201411:32 amRNSVoting Rights and Capital
23rd Jun 20149:00 amRNSNotice of Results
19th Jun 201411:05 amRNSHolding(s) in Company
12th Jun 20147:00 amRNSCEO Appointment
5th Jun 20145:26 pmRNSHolding(s) in Company
2nd Jun 201412:44 pmRNSTotal Voting Rights
2nd Jun 20149:00 amRNSHolding(s) in Company
22nd May 20142:22 pmRNSHolding(s) in Company
13th May 20147:00 amRNSInterim Management Statement
2nd May 20142:04 pmRNSVoting Rights & Capital
9th Apr 201412:36 pmRNSHolding(s) in Company
2nd Apr 201410:55 amRNSTotal Voting Rights
31st Mar 20144:30 pmRNSHolding(s) in Company
3rd Mar 20149:40 amRNSVoting Rights and Capital
25th Feb 20147:01 amRNSRetirement of Chief Executive
25th Feb 20147:00 amRNSInterim Results
17th Feb 20142:58 pmRNSHolding(s) in Company
4th Feb 20141:50 pmRNSVoting Rights and Capital
2nd Jan 20142:12 pmRNSVoting Rights and Capital
20th Dec 201311:32 amRNSNotice of Results
2nd Dec 20135:57 pmRNSTotal Voting Rights
19th Nov 20137:00 amRNSHolding(s) in Company
11th Nov 20134:48 pmRNSHolding(s) in Company
5th Nov 20133:39 pmRNSResult of AGM
5th Nov 20137:00 amRNSInterim Management Statement
4th Nov 201312:23 pmRNSTotal Voting Rights
24th Oct 201311:52 amRNSShare Awards
4th Oct 201311:42 amRNSHolding(s) in Company
2nd Oct 20134:31 pmRNSDirector/PDMR Shareholding
1st Oct 20134:51 pmRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.